Changes in Insulin Resistance in Healthy Volunteers on STRIBILD® Medication

NCT02203461 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Insulin Resistance

Interventions

DRUG: Tenofovir disaproxil fumarate/emtricitabine/elvitegravir/cobicistat
DRUG: Tenofovir disaproxil fumarate/emtricitabine + Lopinavir/ritonavir
DRUG: Tenofovir disaproxil fumarate/emtricitabine + ritonavir-boosted darunavir

Sponsor

Technical University of Munich

Collaborators

[object Object]
[object Object]